Xtreme Shock Blue Raspberry Lemonade
ANSI Advanced Nutrient Science Intl Xtreme Shock Blue Raspberry Lemonade is an 'Other Combinations' supplement with 4 total ingredients. This product provides Niacin at a clinically studied dose of 20 mg. However, it also includes an 'Xtreme Shock Proprietary Blend' of 5550 mg, which lacks transparency regarding individual ingredient dosages. With an N+ Score of 66 and a D grade, this product is rated as average in quality. The proprietary blend makes it difficult to assess the efficacy of other components. It may appeal to those seeking a niacin boost in a flavored drink, but full ingredient transparency is absent.
About This Product
Xtreme Shock Blue Raspberry Lemonade by ANSI Advanced Nutrient Science Intl is a vitamins & minerals supplement containing 4 active ingredients. It has earned an N+ Score of 66/100 (Grade D).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Niacin.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Missing several expected ingredients for its category
Ingredient Analysis (4 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Calories | 8.000 Calorie(s) | N/A |
| Niacin | 20.000 mg | Optimal |
| Total Carbohydrates | 2.000 Gram(s) | N/A |
| Xtreme Shock Proprietary Blend | 5550.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.
